JPRN-jRCTs031180035已完成未知
Elobixibat Research on Stool Bile Acid in PatientsWith Chronic Constipation - Elobixibat Research on Stool Bile Acid in Patients With Chronic Constipation(ELSA)
Hasunuma Tomoko0 个研究点目标入组 29 人开始时间: 2018年10月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 29
研究概览
简要总结
The amount of total bile acids in stools in patients with chronic constipation was significantly decreased and the proportion of secondary bile acids in the stools was increased in comparison with healthy control. By the administration of elobixibat, the amount of fecal bile acids, especially primary one were significantly increased, and symptoms of constipation were improved. It was suggested that the liver production of the primary bile acids was substituting the excreted primary bile acids in the stools.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with chronic constipation
- •(1)Patients aged >=20 years at the time of informed consent
- •(2)Patients whose mean Spontaneous Bowel Movement was <3 times/week from at least 6 months prior to informed consent
- •(3)Patients with one of the following symptoms related to Spontaneous Bowel Movement from at least 6 months prior to informed consent
- •a.Straining among at least 25% of defecations
- •b.Scybalum or hard stool among at least 25% of defecations
- •c.Sensation of incomplete evacuation among at least 25% of defecations
- •(4)Patients whose Spontaneous Bowel Movement frequency was =<5 times for 14 days prior to admission.(=<2 times for the last week of the 2-week run-in)
- •(5)Patients whose average Bristol stool form scale was =<3 for the last week of the 2-week run-in
- •(6)Patients capable of giving written informed consent
- •Healthy volunteers
- •(1)Volunteers aged >=20 years at the time of informed consent
- •(2)Volunteers who have bowel movements almost every day
- •(3)Volunteers who have no disease requiring routine treatment
- •(4)Volunteers capable of giving written informed consent
排除标准
- •Patients with chronic constipation
- •(1)Patients with, or suspected to have, organic constipation, symptomatic constipation or drug-induced constipation
- •(2)Patients with a medical history of gastrointestinal obstruction
- •(3)Patients with abdominal hernia
- •(4)Patients with a surgical history of small or large intestine other than simple appendectomy
- •(5)Patients with a medical history of surgical or endoscopic intervention related to cholecystectomy and papillotomy
- •(6)Patients who are proven to be positive for HBs antigen, anti-HCV antibody, serological reaction of syphilis, or anti- HIV-1, 2 antibodies
- •(7)Patients with current medical history of serious dysfunction related to the kidney (creatinine>=2.00 mg/dL)or the liver (total bilirubin >=3.0 mg/dL or AST or ALT >=100 U/L)
- •(8)Patients with a history of serious drug-induced allergy
- •(9)Patients with a past or current medical history of drug poisoning or alcohol poisoning
- •(10)Pregnant women, lactating women, women with pregnancy suspected
- •(11)Patients who used the rescue medication within 72 hours after bowel movement during the 2-week screening period
- •(12)Patients with soft stool or watery stool (Bristol Stool Form Scale type 6 or 7) in Spontaneous Bowel Movement during the 2-week screening period and during the 1-week baseline period
- •(13)Patients who used the rescue medication more than four times during the 2-week screening period
- •(14)Patients who used prohibited medications/therapies from the beginning of 2-week screening period to the day of hospitalization
- •(15)Patients who used the rescue medication during the 1-week baseline period
- •(16)Patients who were considered as ineligible by the investigator for any other reasons
- •Healthy volunteers
- •(1)Volunteers with a medical history of gastrointestinal obstruction
- •(2)Volunteers with abdominal hernia
- •(3)Volunteers with a surgical history of small or large intestine other than simple appendectomy
- •(4)Volunteers who are proven to be positive for HBs antigen, anti-HCV antibody, serological reaction of syphilis, or anti- HIV-1, 2 antibodies
- •(5)Volunteers with a history of serious drug-induced allergy
- •(6)Volunteers with a past or current medical history of drug poisoning or alcohol poisoning
- •(7)Volunteers women, lactating women, women with pregnancy suspected
- •(8)Volunteers whose mean Spontaneous Bowel Movement was =<3 times/week during the 1-week screening period
- •(9)Volunteers who used prohibited medications/therapies from the beginning of 1-week screening period to the day of hospitalization
- •(10)Volunteers who were considered as ineligible by the investigator for any other reasons
研究者
相似试验
进行中（未招募）
1 期
Changes in stool habits and in the balance and regulation of bile acids after surgical removal of the gall bladderPost cholecystectomy bile acid diarrhoea/malabsorptionMedDRA version: 19.1Level: PTClassification code 10069703Term: Bile acid malabsorptionSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 19.1Level: PTClassification code 10008611Term: CholecystectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10066557Term: Chronic diarrhoeaSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 19.1Level: PTClassification code 10057229Term: Post cholecystectomy syndromeSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-004692-53-DKZealand University Hospital Køge20
已完成
不适用
Effects of Elobixibat on rectal visceral perception in constipated patients over 60 years of agechronic constipationJPRN-jRCTs061200030Manabe Noriaki30
进行中（未招募）
1 期
The prevalence of bile acid diarrhéa and the effect of treatment in patients with microscopic colitisMicroscopic colitisBile acid diarrheaEUCTR2019-002762-12-DKZealand University Hospital54
已完成
不适用
Effect of Bile Acid Secretion and Sequestration on GLP-1 SecretionDiabetes Mellitus, Type 2NCT02445508University Hospital, Gentofte, Copenhagen15
已完成
不适用
Red Yeast Rice for Primary Prevention of HypercholesterolemiaHypercholesterolemiaNCT06301906Chang Gung Memorial Hospital41